25 XP   0   0   10

Cosmos Health Inc.
Buy, Hold or Sell?

Let's analyse Cosmos Health Inc. together

PenkeI guess you are interested in Cosmos Health Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cosmos Health Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cosmos Health Inc.

I send you an email if I find something interesting about Cosmos Health Inc..

Quick analysis of Cosmos Health Inc. (30 sec.)










What can you expect buying and holding a share of Cosmos Health Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$2.45
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$3.37
Expected worth in 1 year
$6.12
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
$5.19
Return On Investment
318.7%

For what price can you sell your share?

Current Price per Share
$1.63
Expected price per share
$0.99 - $2.91
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Cosmos Health Inc. (5 min.)




Live pricePrice per Share (EOD)

$1.63

Intrinsic Value Per Share

$-24.83 - $-16.12

Total Value Per Share

$-21.46 - $-12.75

2. Growth of Cosmos Health Inc. (5 min.)




Is Cosmos Health Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$44m$5.3m$26.7m83.2%

How much money is Cosmos Health Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$6.1m-$1.5m-$4.6m-75.1%
Net Profit Margin-51.0%-10.5%--

How much money comes from the company's main activities?

3. Financial Health of Cosmos Health Inc. (5 min.)




4. Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry (5 min.)




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#411 / 640

Most Revenue
#448 / 640

Most Profit
#493 / 640

Most Efficient
#490 / 640
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Cosmos Health Inc.? (5 min.)

Welcome investor! Cosmos Health Inc.'s management wants to use your money to grow the business. In return you get a share of Cosmos Health Inc..

What can you expect buying and holding a share of Cosmos Health Inc.?

First you should know what it really means to hold a share of Cosmos Health Inc.. And how you can make/lose money.

Speculation

The Price per Share of Cosmos Health Inc. is $1.63. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cosmos Health Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cosmos Health Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.37. Based on the TTM, the Book Value Change Per Share is $0.69 per quarter. Based on the YOY, the Book Value Change Per Share is $0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.61 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cosmos Health Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-4.6%-0.27-16.7%-0.52-31.6%-0.21-12.9%-0.12-7.4%
Usd Book Value Change Per Share0.3420.6%0.6942.1%0.159.1%0.1811.1%0.085.2%
Usd Dividend Per Share0.000.0%0.6137.6%0.2615.8%0.1710.7%0.9759.7%
Usd Total Gains Per Share0.3420.6%1.3079.7%0.4124.9%0.3621.8%1.0664.9%
Usd Price Per Share2.99-2.82-2.63-3.35-2.66-
Price to Earnings Ratio-9.95--9.20-6.22--1.19--3.44-
Price-to-Total Gains Ratio8.91-3.34--3.88--129.18-3,144.97-
Price to Book Ratio0.89-1.02-8.31-6.54--14.94-
Price-to-Total Gains Ratio8.91-3.34--3.88--129.18-3,144.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.63
Number of shares613
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.610.17
Usd Book Value Change Per Share0.690.18
Usd Total Gains Per Share1.300.36
Gains per Quarter (613 shares)796.13217.87
Gains per Year (613 shares)3,184.52871.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1150116833175426445861
23002336763608528911732
3450450509545127813362603
46005673312730170517813474
57506841715915213122274345
690071010019100255726725216
7105081178322285298331176087
8120101346625470340935636958
9135111515028655383540087829
10150121683331840426244538700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%10.028.02.025.0%10.040.02.019.2%
Book Value Change Per Share2.01.01.050.0%8.03.01.066.7%10.08.02.050.0%17.021.02.042.5%20.030.02.038.5%
Dividend per Share2.00.02.050.0%4.00.08.033.3%4.00.016.020.0%5.00.035.012.5%5.00.047.09.6%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%12.07.01.060.0%19.020.01.047.5%22.029.01.042.3%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Cosmos Health Inc.

About Cosmos Health Inc.

Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Fundamental data was last updated by Penke on 2023-09-09 09:54:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Cosmos Health Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cosmos Health Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -7.9% means that $-0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cosmos Health Inc.:

  • The MRQ is -7.9%. The company is making a loss. -1
  • The TTM is -51.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7.9%TTM-51.0%+43.0%
TTM-51.0%YOY-10.5%-40.5%
TTM-51.0%5Y-25.5%-25.5%
5Y-25.5%10Y-32.7%+7.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%2.3%-10.2%
TTM-51.0%1.9%-52.9%
YOY-10.5%2.9%-13.4%
5Y-25.5%1.4%-26.9%
10Y-32.7%2.2%-34.9%
1.1.2. Return on Assets

Shows how efficient Cosmos Health Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • -1.4% Return on Assets means that Cosmos Health Inc. generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cosmos Health Inc.:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-9.4%+8.0%
TTM-9.4%YOY-3.2%-6.2%
TTM-9.4%5Y-7.4%-2.0%
5Y-7.4%10Y-23.5%+16.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%0.2%-1.6%
TTM-9.4%0.1%-9.5%
YOY-3.2%0.4%-3.6%
5Y-7.4%0.3%-7.7%
10Y-23.5%0.5%-24.0%
1.1.3. Return on Equity

Shows how efficient Cosmos Health Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • -2.2% Return on Equity means Cosmos Health Inc. generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cosmos Health Inc.:

  • The MRQ is -2.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-23.8%+21.5%
TTM-23.8%YOY-31.0%+7.3%
TTM-23.8%5Y-37.0%+13.2%
5Y-37.0%10Y21.3%-58.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.2%1.0%-3.2%
TTM-23.8%0.7%-24.5%
YOY-31.0%0.9%-31.9%
5Y-37.0%0.4%-37.4%
10Y21.3%0.9%+20.4%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Cosmos Health Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cosmos Health Inc. is operating .

  • Measures how much profit Cosmos Health Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -19.0% means the company generated $-0.19  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cosmos Health Inc.:

  • The MRQ is -19.0%. The company is operating very inefficient. -2
  • The TTM is -20.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-19.0%TTM-20.6%+1.6%
TTM-20.6%YOY-3.4%-17.2%
TTM-20.6%5Y-5.0%-15.6%
5Y-5.0%10Y-29.5%+24.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.0%2.9%-21.9%
TTM-20.6%1.8%-22.4%
YOY-3.4%5.3%-8.7%
5Y-5.0%4.7%-9.7%
10Y-29.5%3.2%-32.7%
1.2.2. Operating Ratio

Measures how efficient Cosmos Health Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are $1.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cosmos Health Inc.:

  • The MRQ is 1.208. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.603. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.208TTM1.603-0.395
TTM1.603YOY1.238+0.365
TTM1.6035Y1.265+0.338
5Y1.26510Y0.973+0.292
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2081.378-0.170
TTM1.6031.393+0.210
YOY1.2381.383-0.145
5Y1.2651.416-0.151
10Y0.9731.188-0.215
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Cosmos Health Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cosmos Health Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.19 means the company has $2.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cosmos Health Inc.:

  • The MRQ is 2.185. The company is able to pay all its short-term debts. +1
  • The TTM is 2.098. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.185TTM2.098+0.087
TTM2.098YOY1.258+0.840
TTM2.0985Y1.238+0.860
5Y1.23810Y1.291-0.053
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1851.835+0.350
TTM2.0981.886+0.212
YOY1.2582.122-0.864
5Y1.2382.351-1.113
10Y1.2912.086-0.795
1.3.2. Quick Ratio

Measures if Cosmos Health Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 1.44 means the company can pay off $1.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cosmos Health Inc.:

  • The MRQ is 1.443. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.354. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.443TTM1.354+0.089
TTM1.354YOY0.922+0.432
TTM1.3545Y0.799+0.555
5Y0.79910Y0.776+0.023
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4430.758+0.685
TTM1.3540.782+0.572
YOY0.9221.048-0.126
5Y0.7991.084-0.285
10Y0.7761.089-0.313
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Cosmos Health Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cosmos Health Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cosmos Health Inc. to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that Cosmos Health Inc. assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cosmos Health Inc.:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.520. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.520-0.162
TTM0.520YOY0.889-0.369
TTM0.5205Y0.966-0.446
5Y0.96610Y1.138-0.172
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3580.428-0.070
TTM0.5200.430+0.090
YOY0.8890.393+0.496
5Y0.9660.401+0.565
10Y1.1380.402+0.736
1.4.2. Debt to Equity Ratio

Measures if Cosmos Health Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 55.7% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cosmos Health Inc.:

  • The MRQ is 0.557. The company is very able to pay all its debts with equity. +2
  • The TTM is 2.459. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ0.557TTM2.459-1.902
TTM2.459YOY8.673-6.213
TTM2.4595Y8.296-5.836
5Y8.29610Y4.618+3.678
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5570.682-0.125
TTM2.4590.693+1.766
YOY8.6730.617+8.056
5Y8.2960.689+7.607
10Y4.6180.712+3.906
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Cosmos Health Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cosmos Health Inc. generates.

  • Above 15 is considered overpriced but always compare Cosmos Health Inc. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -9.95 means the investor is paying $-9.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cosmos Health Inc.:

  • The EOD is -5.426. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.953. Based on the earnings, the company is expensive. -2
  • The TTM is -9.204. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.426MRQ-9.953+4.527
MRQ-9.953TTM-9.204-0.749
TTM-9.204YOY6.221-15.425
TTM-9.2045Y-1.193-8.011
5Y-1.19310Y-3.440+2.247
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-5.4265.016-10.442
MRQ-9.9533.693-13.646
TTM-9.2042.965-12.169
YOY6.2215.146+1.075
5Y-1.1936.616-7.809
10Y-3.44013.646-17.086
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cosmos Health Inc.:

  • The EOD is -0.582. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.067. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.015. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.582MRQ-1.067+0.485
MRQ-1.067TTM-1.015-0.052
TTM-1.015YOY-4.623+3.608
TTM-1.0155Y-24.635+23.620
5Y-24.63510Y-14.340-10.295
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.582-0.400-0.182
MRQ-1.067-0.678-0.389
TTM-1.015-1.296+0.281
YOY-4.623-2.222-2.401
5Y-24.635-1.632-23.003
10Y-14.340-3.189-11.151
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cosmos Health Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.89 means the investor is paying $0.89 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cosmos Health Inc.:

  • The EOD is 0.484. Based on the equity, the company is cheap. +2
  • The MRQ is 0.887. Based on the equity, the company is cheap. +2
  • The TTM is 1.019. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.484MRQ0.887-0.404
MRQ0.887TTM1.019-0.132
TTM1.019YOY8.312-7.293
TTM1.0195Y6.540-5.521
5Y6.54010Y-14.943+21.483
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.4841.640-1.156
MRQ0.8871.671-0.784
TTM1.0191.655-0.636
YOY8.3122.095+6.217
5Y6.5402.534+4.006
10Y-14.9433.327-18.270
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cosmos Health Inc..

3.1. Institutions holding Cosmos Health Inc.

Institutions are holding 4.591% of the shares of Cosmos Health Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-03-31BlackRock Inc2.049102677972599883329.3379
2023-06-30Geode Capital Management, LLC0.727809511127933.0254
2023-06-30Sabby Management LLC0.26790.08563500600
2023-06-30Group One Trading, LP0.25550.000333385333850
2023-06-30Susquehanna International Group, LLP0.2419031607316070
2023-06-30Bank of America Corp0.1921025105251050
2023-03-31State Street Corporation0.1633021343213430
2023-06-30Northern Trust Corp0.15730205547233.6458
2023-06-30Dimensional Fund Advisors, Inc.0.1445018881188810
2023-06-30CIBC Global Asset Management Inc0.10890.00021422600
2023-06-30Compagnie Lombard, Odier SCA0.0024032000
2023-06-30Morgan Stanley - Brokerage Accounts0.00150200-1000-83.3333
2023-06-30Cornerstone Planning Group LLC0.00150.000220000
2023-03-31IFP Advisors, LLC0.00080.00011001000
2023-06-30Wells Fargo & Co0.000506723.0769
2023-03-31JANE STREET GROUP, LLC000-10179-100
2023-03-31Cypress Capital Management, LLC000-200-100
2023-03-31UBS Group AG000-1996-100
2023-03-31Jump Financial, LLC000-13447-100
2023-03-31Diametric Capital, LP000-52028-100
Total 4.3150.0864563902+315077+55.9%

3.2. Funds holding Cosmos Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-07-31Vanguard Extended Market Index Investor1.03170.000213483400
2023-06-30Fidelity® Extended Market Index0.40720.00055322200
2023-06-30BlackRock Extended Mkt Composite0.31230.00084081000
2023-06-30BlackRock Extended Equity Market K0.27360.0008357533981.1257
2023-08-28iShares Micro-Cap ETF0.16440.00312149000
2023-06-30Fidelity® Total Market Index0.12410.00011622200
2023-05-31CIBC US Broad Market Index0.10890.00421422600
2023-06-30NT Ext Equity Mkt Idx Fd - NL0.0990.00071293500
2023-06-30Fidelity® Series Total Market Index0.09550.00011247600
2023-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.08330.000710883-65-0.5937
2023-06-30Northern Trust Extended Eq Market Idx0.05280.0004689600
2023-06-30NT Ext Equity Mkt Idx Fd - L0.05280.0004689600
2023-06-30Spartan Total Market Index Pool E0.04280.0001558700
2023-06-30Fidelity® NASDAQ Composite Index®0.0350.000145742793156.822
2023-06-30DFA US Targeted Value I0.03420.0001446700
2023-06-30Extended Equity Market Fund M0.03170.000841403184333.0544
2023-06-30Spartan Extended Market Index Pool E0.02320.0005303000
2023-06-301290 VT Micro Cap K0.01390.0035181718170
2023-06-30DFA US Small Cap I0.01320172300
2023-06-30Victory Extended Market Index0.00770.00041012-21-2.0329
Total 3.00730.0175392993+8106+2.1%

3.3. Insider Transactions

Insiders are holding 14.907% of the shares of Cosmos Health Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-07-20Grigorios SiokasBUY1814512.481327885
2023-06-06Grigorios SiokasBUY447423.921146434
2023-04-27Grigorios SiokasBUY447424.641141960
2023-04-21Grigorios SiokasBUY447424.491137486
2023-04-07Grigorios SiokasBUY223824.371133012
2022-12-19Grigorios SiokasBUY26087011.51130774
2022-11-28Grigorios SiokasBUY3205015.5805417
2022-10-20Grigorios SiokasBUY5000003773366
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cosmos Health Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3360.687-51%0.149+126%0.182+85%0.085+295%
Book Value Per Share--3.3702.458+37%0.393+758%0.396+751%0.203+1559%
Current Ratio--2.1852.098+4%1.258+74%1.238+77%1.291+69%
Debt To Asset Ratio--0.3580.520-31%0.889-60%0.966-63%1.138-69%
Debt To Equity Ratio--0.5572.459-77%8.673-94%8.296-93%4.618-88%
Dividend Per Share---0.612-100%0.257-100%0.174-100%0.973-100%
Eps---0.075-0.273+263%-0.515+586%-0.210+179%-0.121+62%
Free Cash Flow Per Share---0.701-0.601-14%-0.148-79%-0.226-68%-0.115-84%
Free Cash Flow To Equity Per Share---0.7150.585-222%-0.038-95%0.096-846%0.097-833%
Gross Profit Margin--1.3241.097+21%1.080+23%1.038+28%0.969+37%
Intrinsic Value_10Y_max---16.116--------
Intrinsic Value_10Y_min---24.828--------
Intrinsic Value_1Y_max---0.629--------
Intrinsic Value_1Y_min---1.443--------
Intrinsic Value_3Y_max---2.642--------
Intrinsic Value_3Y_min---5.267--------
Intrinsic Value_5Y_max---5.560--------
Intrinsic Value_5Y_min---10.081--------
Market Cap21301981.000-83%39075413.00036902741.625+6%37848143.830+3%44616080.376-12%35188812.282+11%
Net Profit Margin---0.079-0.510+542%-0.105+32%-0.255+221%-0.327+311%
Operating Margin---0.190-0.206+8%-0.034-82%-0.050-73%-0.295+55%
Operating Ratio--1.2081.603-25%1.238-2%1.265-5%0.973+24%
Pb Ratio0.484-83%0.8871.019-13%8.312-89%6.540-86%-14.943+1784%
Pe Ratio-5.426+45%-9.953-9.204-8%6.221-260%-1.193-88%-3.440-65%
Price Per Share1.630-83%2.9902.824+6%2.633+14%3.354-11%2.663+12%
Price To Free Cash Flow Ratio-0.582+45%-1.067-1.015-5%-4.623+333%-24.635+2209%-14.340+1244%
Price To Total Gains Ratio4.858-83%8.9123.341+167%-3.879+144%-129.183+1550%3144.974-100%
Quick Ratio--1.4431.354+7%0.922+56%0.799+81%0.776+86%
Return On Assets---0.014-0.094+556%-0.032+120%-0.074+415%-0.235+1543%
Return On Equity---0.022-0.238+966%-0.310+1292%-0.370+1560%0.213-110%
Total Gains Per Share--0.3361.299-74%0.405-17%0.355-6%1.058-68%
Usd Book Value--44041472.00032127689.500+37%5391137.500+717%5219532.900+744%2678067.900+1545%
Usd Book Value Change Per Share--0.3360.687-51%0.149+126%0.182+85%0.085+295%
Usd Book Value Per Share--3.3702.458+37%0.393+758%0.396+751%0.203+1559%
Usd Dividend Per Share---0.612-100%0.257-100%0.174-100%0.973-100%
Usd Eps---0.075-0.273+263%-0.515+586%-0.210+179%-0.121+62%
Usd Free Cash Flow---9157651.000-7849164.250-14%-2023284.000-78%-2976370.000-67%-1479961.975-84%
Usd Free Cash Flow Per Share---0.701-0.601-14%-0.148-79%-0.226-68%-0.115-84%
Usd Free Cash Flow To Equity Per Share---0.7150.585-222%-0.038-95%0.096-846%0.097-833%
Usd Market Cap21301981.000-83%39075413.00036902741.625+6%37848143.830+3%44616080.376-12%35188812.282+11%
Usd Price Per Share1.630-83%2.9902.824+6%2.633+14%3.354-11%2.663+12%
Usd Profit---981530.000-6148419.750+526%-1530523.250+56%-2619692.650+167%-1484075.075+51%
Usd Revenue--12363429.00012120506.750+2%14790104.500-16%12403226.1500%7931951.000+56%
Usd Total Gains Per Share--0.3361.299-74%0.405-17%0.355-6%1.058-68%
 EOD+2 -6MRQTTM+24 -12YOY+23 -135Y+21 -1510Y+21 -15

4.2. Fundamental Score

Let's check the fundamental score of Cosmos Health Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.426
Price to Book Ratio (EOD)Between0-10.484
Net Profit Margin (MRQ)Greater than0-0.079
Operating Margin (MRQ)Greater than0-0.190
Quick Ratio (MRQ)Greater than11.443
Current Ratio (MRQ)Greater than12.185
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.557
Return on Equity (MRQ)Greater than0.15-0.022
Return on Assets (MRQ)Greater than0.05-0.014
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Cosmos Health Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.189
Ma 20Greater thanMa 501.426
Ma 50Greater thanMa 1001.411
Ma 100Greater thanMa 2002.323
OpenGreater thanClose1.670
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-06-302022-09-302022-12-312023-03-312023-06-30
Total Other Income Expense Net -1,157-74-1,231-575-1,805-1,415-3,2204,8911,671



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets68,592
Total Liabilities24,551
Total Stockholder Equity44,041
 As reported
Total Liabilities 24,551
Total Stockholder Equity+ 44,041
Total Assets = 68,592

Assets

Total Assets68,592
Total Current Assets44,210
Long-term Assets44,210
Total Current Assets
Cash And Cash Equivalents 2,233
Short-term Investments 19
Net Receivables 26,929
Inventory 4,799
Other Current Assets 10,229
Total Current Assets  (as reported)44,210
Total Current Assets  (calculated)44,210
+/-0
Long-term Assets
Property Plant Equipment 11,974
Goodwill 50
Intangible Assets 3,732
Long-term Assets Other 8,626
Long-term Assets  (as reported)24,382
Long-term Assets  (calculated)24,382
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,232
Long-term Liabilities4,319
Total Stockholder Equity44,041
Total Current Liabilities
Short-term Debt 5,943
Short Long Term Debt 5,639
Accounts payable 11,632
Other Current Liabilities 1,982
Total Current Liabilities  (as reported)20,232
Total Current Liabilities  (calculated)25,196
+/- 4,965
Long-term Liabilities
Long term Debt 2,517
Capital Lease Obligations 1,304
Long-term Liabilities Other 802
Long-term Liabilities  (as reported)4,319
Long-term Liabilities  (calculated)4,623
+/- 304
Total Stockholder Equity
Common Stock11
Retained Earnings -67,674
Other Stockholders Equity 112,045
Total Stockholder Equity (as reported)44,041
Total Stockholder Equity (calculated)44,382
+/- 341
Other
Capital Stock383
Cash and Short Term Investments 2,252
Common Stock Shares Outstanding 10,820
Current Deferred Revenue675
Liabilities and Stockholders Equity 68,592
Net Debt 7,228
Net Invested Capital 51,826
Net Working Capital 23,978
Short Long Term Debt Total 9,461



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-03-312011-12-312011-09-302011-03-312010-12-312010-09-302010-03-312009-12-312009-09-30
> Total Assets 
0
15
10
0
1
61
15
0
2
0
0
6
19
501
867
867
2,104
7,220
7,235
7,235
6,423
6,480
658
658
890
2,106
3,119
3,119
7,249
10,835
10,676
10,676
13,583
19,506
20,695
20,695
21,830
21,280
23,880
23,880
33,855
38,569
43,844
43,844
45,157
47,677
49,429
49,429
47,842
45,621
68,039
68,039
68,592
68,59268,03968,03945,62147,84249,42949,42947,67745,15743,84443,84438,56933,85523,88023,88021,28021,83020,69520,69519,50613,58310,67610,67610,8357,2493,1193,1192,1068906586586,4806,4237,2357,2357,2202,104867867501196002015611010150
   > Total Current Assets 
0
15
10
0
1
61
15
0
2
0
0
6
19
501
0
865
2,104
7,214
0
7,213
6,367
6,402
0
547
764
1,933
2,637
2,637
6,628
10,055
9,511
9,511
12,961
19,223
18,347
18,347
19,036
18,601
21,179
21,179
31,218
35,876
40,773
40,773
42,315
44,284
40,879
40,879
40,000
38,849
56,045
56,045
44,210
44,21056,04556,04538,84940,00040,87940,87944,28442,31540,77340,77335,87631,21821,17921,17918,60119,03618,34718,34719,22312,9619,5119,51110,0556,6282,6372,6371,93376454706,4026,3677,21307,2142,1048650501196002015611010150
       Cash And Cash Equivalents 
0
15
5
0
1
61
15
0
0
0
0
6
19
501
864
864
841
84
447
7,180
6,334
156
198
198
474
620
716
717
780
1,352
783
783
1,154
1,233
864
864
887
1,180
39
39
2,407
1,082
628
628
806
1,034
286
286
562
312
20,750
20,750
2,233
2,23320,75020,7503125622862861,0348066286281,0822,40739391,1808878648641,2331,1547837831,3527807177166204741981981566,3347,1804478484186486450119600001561105150
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,826
6,275
2,717
2,717
1,173
405
243
243
254
211
223
223
216
211
7
7
10
10
15
15
19
1915151010772112162232232112542432434051,1732,7172,7176,2751,82600000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,228
62
0
0
0
0
0
97
126
553
794
794
2,225
2,859
1,427
1,427
1,999
2,415
4,943
4,943
5,756
6,205
9,268
9,268
15,282
19,726
26,909
26,909
28,679
30,114
30,137
30,137
28,891
27,590
22,762
26,398
26,929
26,92926,39822,76227,59028,89130,13730,13730,11428,67926,90926,90919,72615,2829,2689,2686,2055,7564,9434,9432,4151,9991,4271,4272,8592,2257947945531269700000621,2280000000000000000
       Other Current Assets 
0
0
5
0
0
0
0
0
1
0
0
0
0
0
3
2
2
7,027
6,766
33
33
6,214
61
61
0
379
663
662
2,253
3,386
4,207
4,207
5,906
6,874
4,867
6,620
649
555
665
665
563
601
9,720
1,103
1,234
1,166
1,046
1,046
1,095
1,016
5,431
5,431
10,229
10,2295,4315,4311,0161,0951,0461,0461,1661,2341,1039,7206015636656655556496,6204,8676,8745,9064,2074,2073,3862,253662663379061616,21433336,7667,02722300000100000500
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
7
0
22
56
78
0
110
126
173
0
482
621
780
0
1,165
622
283
0
2,348
2,794
2,679
2,701
2,701
2,637
2,693
3,071
3,071
2,842
3,394
8,551
8,551
7,843
6,772
11,994
11,994
24,382
24,38211,99411,9946,7727,8438,5518,5513,3942,8423,0713,0712,6932,6372,7012,7012,6792,7942,34802836221,1650780621482017312611007856220702000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
46
39
51
51
56
57
53
53
73
80
114
115
125
125
1,426
1,426
1,710
1,638
1,735
1,735
1,675
1,700
1,757
1,757
1,578
1,969
1,881
1,881
1,619
1,450
0
2,930
11,974
11,9742,93001,4501,6191,8811,8811,9691,5781,7571,7571,7001,6751,7351,7351,6381,7101,4261,426125125115114807353535756515139461212000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-41,952
-37,985
-35,969
50
102
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
505050505050505050505050505050505010250-35,969-37,985-41,9520000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
48
46
44
42
41,994
38,023
36,005
247
195
233
226
214
214
197
189
181
181
164
459
443
443
691
633
657
657
3,732
3,73265765763369144344345916418118118919721421422623319524736,00538,02341,99442444648000000020000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
7
10
13
11
39
60
67
70
116
429
607
548
700
1,051
1,189
534
122
625
616
801
765
702
690
546
578
900
1,076
872
743
6,007
5,904
5,325
4,640
0
0
0
0004,6405,3255,9046,0077438721,0769005785466907027658016166251225341,1891,051700548607429116706760391113107350000000000000000
> Total Liabilities 
0
17
18
18
16
5
20
117
162
213
339
301
359
1,404
921
921
678
1,526
1,761
1,761
1,613
1,714
1,906
1,905
2,342
3,670
4,872
4,871
9,880
13,602
13,704
13,704
17,013
16,231
24,012
24,012
26,614
27,665
30,340
30,340
39,382
43,339
48,005
48,005
44,773
43,026
45,050
45,050
39,688
40,466
28,382
28,382
24,551
24,55128,38228,38240,46639,68845,05045,05043,02644,77348,00548,00543,33939,38230,34030,34027,66526,61424,01224,01216,23117,01313,70413,70413,6029,8804,8714,8723,6702,3421,9051,9061,7141,6131,7611,7611,5266789219211,404359301339213162117205161818170
   > Total Current Liabilities 
0
17
18
18
0
5
20
117
162
213
339
301
359
1,404
921
921
678
1,526
1,761
1,761
1,613
1,664
1,906
1,905
2,342
3,670
4,872
4,871
9,880
13,602
13,704
13,704
15,459
14,676
22,274
22,274
24,542
25,631
28,241
28,241
37,292
41,209
34,793
34,793
31,898
37,427
29,928
29,928
35,871
36,904
21,749
21,749
20,232
20,23221,74921,74936,90435,87129,92829,92837,42731,89834,79334,79341,20937,29228,24128,24125,63124,54222,27422,27414,67615,45913,70413,70413,6029,8804,8714,8723,6702,3421,9051,9061,6641,6131,7611,7611,5266789219211,40435930133921316211720501818170
       Short-term Debt 
0
16
16
0
0
5
5
12
15
125
154
125
-510
0
0
165
165
165
0
504
536
540
0
441
802
2,265
3,199
3,199
6,675
9,950
10,179
10,179
11,722
11,990
0
15,023
17,480
18,425
18,653
18,851
27,116
30,370
20,492
20,492
16,581
23,170
0
13,556
20,462
21,120
0
8,305
5,943
5,9438,305021,12020,46213,556023,17016,58120,49220,49230,37027,11618,85118,65318,42517,48015,023011,99011,72210,17910,1799,9506,6753,1993,1992,2658024410540536504016516516500-5101251541251512550016160
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
3,413
6,675
9,950
10,179
13,704
0
0
0
15,335
17,284
18,249
18,653
20,967
26,974
30,224
20,663
17,758
16,332
22,915
13,345
14,113
20,247
20,881
8,041
5,516
5,639
5,6395,5168,04120,88120,24714,11313,34522,91516,33217,75820,66330,22426,97420,96718,65318,24917,28415,33500013,70410,1799,9506,6753,4133,19900000000000000000000000000
       Accounts payable 
0
0
0
2
0
5
0
0
0
3
185
176
219
754
530
717
249
261
159
165
106
86
337
229
176
272
592
592
1,973
2,338
2,166
1,778
1,914
2,031
6,024
5,933
6,605
6,930
8,802
8,562
9,629
10,193
11,974
11,974
12,450
11,712
12,325
12,127
11,171
11,409
11,919
11,919
11,632
11,63211,91911,91911,40911,17112,12712,32511,71212,45011,97411,97410,1939,6298,5628,8026,9306,6055,9336,0242,0311,9141,7782,1662,3381,973592592272176229337861061651592612497175307542191761853000502000
       Other Current Liabilities 
0
1
3
16
0
-5
20
105
147
210
0
0
150
150
188
38
264
1,100
6
1,091
971
1,038
62
1,173
1,364
1,133
1,081
1,081
1,232
1,314
1,420
1,747
1,822
655
1,227
251
360
75
589
582
393
627
2,304
2,304
2,848
780
2,626
1,301
4,238
4,376
917
1,524
1,982
1,9821,5249174,3764,2381,3012,6267802,8482,3042,304627393582589753602511,2276551,8221,7471,4201,3141,2321,0811,0811,1331,3641,173621,0389711,09161,100264381881501500021014710520-5016310
   > Long-term Liabilities 
0
16
16
2
16
5
5
12
15
3
339
301
1,254
1,254
0
882
414
426
0
670
642
50
0
733
978
2,537
0
3,791
8,648
12,288
0
11,957
1,555
1,555
0
1,738
2,072
2,034
2,099
2,099
2,091
2,131
13,212
13,212
12,875
5,599
15,122
15,122
3,816
3,561
6,633
6,633
4,319
4,3196,6336,6333,5613,81615,12215,1225,59912,87513,21213,2122,1312,0912,0992,0992,0342,0721,73801,5551,55511,957012,2888,6483,79102,537978733050642670042641488201,2541,254301339315125516216160
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,728
0
02,728000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184
165
168
165
109
107
109
114
107
103
104
101
0
0
0
0
0
0
0
00000001011041031071141091071091651681651840000000000000000000000000000000000
> Total Stockholder Equity
0
-2
-8
-17
-15
56
-5
-117
-160
-213
-339
-295
-340
-903
0
-54
1,426
5,695
5,474
5,474
4,811
4,766
0
-1,248
-1,452
-1,564
-1,753
-1,753
-2,631
-2,767
-3,028
-3,028
-3,431
3,275
-3,317
-3,317
-4,784
-6,385
-6,461
-6,461
-5,528
-4,770
-4,161
-4,161
385
4,651
4,379
4,379
8,155
5,156
39,657
39,657
44,041
44,04139,65739,6575,1568,1554,3794,3794,651385-4,161-4,161-4,770-5,528-6,461-6,461-6,385-4,784-3,317-3,3173,275-3,431-3,028-3,028-2,767-2,631-1,753-1,753-1,564-1,452-1,24804,7664,8115,4745,4745,6951,426-540-903-340-295-339-213-160-117-556-15-17-8-20
   Common Stock
0
20
21
24
24
25
25
25
25
25
25
25
25
126
126
126
126
126
126
126
126
126
126
126
126
126
126
126
128
128
13
13
13
13
14
14
13
13
13
13
13
13
13
13
17
17
18
18
24
26
0
11
11
1111026241818171713131313131313131414131313131281281261261261261261261261261261261261261261261262525252525252525242421200
   Retained Earnings Total Equity0-66,6930-34,3460000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-52
-73
-3,793
-3,813
-3,901
-3,962
-4,178
-4,233
-4,293
-4,535
-4,593
-16
-16
0
11
-56
-540
0
-681
-1,131
-1,075
0
-1,106
-1,127
-1,144
0
-1,050
-1,177
-1,229
0
-1,385
-1,339
-34
0
33
62
151
0
-16
23
103
855
855
382
167
0
-152
-1,586
-2,615
0
-1,133
-713
-713-1,1330-2,615-1,586-152016738285585510323-16015162330-34-1,339-1,3850-1,229-1,177-1,0500-1,144-1,127-1,1060-1,075-1,131-6810-540-56110-16-16-4,593-4,535-4,293-4,233-4,178-3,962-3,901-3,813-3,793-73-520
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,676
0
112,303
0
0112,303039,6760000000000000000000000000000000000000000000000000
   Treasury Stock0-8170-81700000000000000000-96-96000000000000000000000000000000
   Other Stockholders Equity 
0
29
45
3,751
3,774
3,933
3,933
4,036
4,048
4,055
4,172
4,274
-435
-435
0
-433
-428
-425
0
-258
-229
-229
0
133
134
134
-1,050
174
2,293
2,410
-1,385
5,557
7,380
9,574
33
12,908
13,171
13,114
-16
13,114
13,114
13,034
13,721
13,721
23,290
29,707
-152
38,859
59,045
60,378
0
106,639
112,045
112,045106,639060,37859,04538,859-15229,70723,29013,72113,72113,03413,11413,114-1613,11413,17112,908339,5747,3805,557-1,3852,4102,293174-1,0501341341330-229-229-2580-425-428-4330-435-4354,2744,1724,0554,0484,0363,9333,9333,7743,75145290



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.